WallStSmart

Hinge Health, Inc. (HNGE)vsNational Research Corp (NRC)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Hinge Health, Inc. generates 414% more annual revenue ($720.06M vs $140.00M). HNGE leads profitability with a 15.1% profit margin vs 4.2%. HNGE trades at a lower P/E of 11.3x. HNGE earns a higher WallStSmart Score of 52/100 (C-).

HNGE

Buy

52

out of 100

Grade: C-

Growth: 7.3Profit: 6.0Value: 6.7Quality: 5.0
Piotroski: 3/9Altman Z: -2.69

NRC

Hold

42

out of 100

Grade: D

Growth: 2.7Profit: 6.0Value: 6.0Quality: 3.0
Piotroski: 3/9Altman Z: 1.32
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

Intrinsic value data unavailable for HNGE.

NRCUndervalued (+51.3%)

Margin of Safety

+51.3%

Fair Value

$28.23

Current Price

$21.12

$7.11 discount

UndervaluedFair: $28.23Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

HNGE3 strengths · Avg: 10.0/10
P/E RatioValuation
11.3x10/10

Attractively priced relative to earnings

Revenue GrowthGrowth
53.0%10/10

Revenue surging 53.0% year-over-year

Debt/EquityHealth
0.0210/10

Conservative balance sheet, low leverage

NRC1 strengths · Avg: 10.0/10
Return on EquityProfitability
89.4%10/10

Every $100 of equity generates 89 in profit

Areas to Watch

HNGE4 concerns · Avg: 2.3/10
Piotroski F-ScoreQuality
3/93/10

Weak financial health signals

Price/BookValuation
22.1x2/10

Trading at 22.1x book value

Return on EquityProfitability
-197.2%2/10

ROE of -197.2% — below average capital efficiency

EPS GrowthGrowth
-68.4%2/10

Earnings declined 68.4%

NRC4 concerns · Avg: 3.3/10
Revenue GrowthGrowth
4.0%4/10

4.0% revenue growth

Market CapQuality
$476.23M3/10

Smaller company, higher risk/reward

Profit MarginProfitability
4.2%3/10

4.2% margin — thin

Piotroski F-ScoreQuality
3/93/10

Weak financial health signals

Comparative Analysis Report

WallStSmart Research

Bull Case : HNGE

The strongest argument for HNGE centers on P/E Ratio, Revenue Growth, Debt/Equity. Profitability is solid with margins at 15.1% and operating margin at 19.0%. Revenue growth of 53.0% demonstrates continued momentum.

Bull Case : NRC

The strongest argument for NRC centers on Return on Equity. PEG of 1.32 suggests the stock is reasonably priced for its growth.

Bear Case : HNGE

The primary concerns for HNGE are Piotroski F-Score, Price/Book, Return on Equity.

Bear Case : NRC

The primary concerns for NRC are Revenue Growth, Market Cap, Profit Margin. A P/E of 89.7x leaves little room for execution misses. Debt-to-equity of 13.75 is elevated, increasing financial risk.

Key Dynamics to Monitor

HNGE profiles as a growth stock while NRC is a value play — different risk/reward profiles.

HNGE is growing revenue faster at 53.0% — sustainability is the question.

HNGE generates stronger free cash flow (100M), providing more financial flexibility.

Monitor HEALTH INFORMATION SERVICES industry trends, competitive dynamics, and regulatory changes.

Bottom Line

HNGE scores higher overall (52/100 vs 42/100), backed by strong 15.1% margins and 53.0% revenue growth. NRC offers better value entry with a 51.3% margin of safety. Both earn "Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Hinge Health, Inc.

HEALTHCARE · HEALTH INFORMATION SERVICES · USA

Hinge Health, Inc. develops health care software for joint and muscle health. The company is headquartered in San Francisco, California.

Visit Website →

National Research Corp

HEALTHCARE · HEALTH INFORMATION SERVICES · USA

National Research Corporation provides analytics and information that make it easy to measure and improve the patient and employee experience in the United States and Canada. The company is headquartered in Lincoln, Nebraska.

Want to dig deeper into these stocks?